The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dacepton 5 mg/ml solution for infusion

5 milligram(s)/millilitre Solution for infusion

EVER Valinject GmbH PA1774/001/002

Main Information

Trade NameDacepton 5 mg/ml solution for infusion
Active SubstancesApomorphine hydrochloride hemihydrate
Strength5 milligram(s)/millilitre
Dosage FormSolution for infusion
Licence HolderEVER Valinject GmbH
Licence NumberPA1774/001/002

Group Information

ATC CodeN04BC Dopamine agonists
N04BC07 apomorphine

Status

Authorised/WithdrawnAuthorised
Licence Issued09/05/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back